Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.
Market Cap | 987.019 Million | Shares Outstanding | 43.328 Million | Avg 30-day Volume | 105.644 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.08 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -43.796 Million |
Price to Book Value | 0.6786 | Operating Margin | 0.0 | Enterprise Value | -30.783 Million |
Current Ratio | 71.492 | EPS Growth | 0.585 | Quick Ratio | 69.493 |
1 Yr BETA | -0.3507 | 52-week High/Low | 26.43 / 1.18 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 23.9241 | Altman Z-Score | 26.1064 | Free Cash Flow to Firm | -36.114 Million |
Please sign in first
652.2 Thousand total shares from 7 transactions
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
2,269,637 | 2023-02-15 | 3 | |
ACCESS INDUSTRIES HOLDINGS LLC |
|
3,141,759 | 2023-02-15 | 2 |
|
2,269,637 | 2023-02-15 | 3 | |
|
7,000 | 2022-12-29 | 1 | |
|
2,340,772 | 2022-12-29 | 1 | |
|
0 | 2022-12-29 | 2 | |
QUISEL JOHN D CHIEF EXECUTIVE OFFICER |
|
0 | 2022-12-29 | 2 |
|
1,173,482 | 2022-12-29 | 2 | |
ATLAS VENTURE ASSOCIATES X, L.P. ATLAS VENTURE ASSOCIATES X, LLC ATLAS VENTURE OPPORTUNITY FUND I, L.P. |
|
3,192,459 | 2022-12-29 | 1 |
|
0 | 2022-12-29 | 2 | |
|
7,000 | 2022-12-29 | 2 | |
|
7,000 | 2022-12-29 | 2 | |
|
7,000 | 2022-12-29 | 2 | |
ATLAS VENTURE OPPORTUNITY FUND II, L.P. |
|
218,326 | 2022-12-29 | 1 |
BRYCE JOANNE CHIEF FINANCIAL OFFICER |
|
3,452 | 2022-12-29 | 2 |
YU JONATHAN YEN-WEN CHIEF BUSINESS OFFICER |
|
0 | 2022-12-29 | 2 |
KHARA RAHUL GENERAL COUNSEL |
|
0 | 2022-12-29 | 2 |
SAVAGE WILLIAM JACOB CHIEF MEDICAL OFFICER |
|
20,325 | 2022-12-29 | 2 |
MACDONALD BRIAN RICHARD CHIEF INNOVATION OFFICER |
|
28,496 | 2022-12-29 | 2 |
|
5,247,500 | 2022-10-26 | 3 | |
PIEKOS BRIAN CFO |
|
17,615 | 2022-05-31 | 1 |
MEYENBURG JASON PATRICK CHIEF EXECUTIVE OFFICER |
|
123,600 | 2022-01-03 | 0 |
|
17,245 | 2021-10-04 | 0 | |
|
17,245 | 2021-10-04 | 0 | |
|
17,245 | 2021-10-04 | 0 | |
|
428,745 | 2021-10-04 | 0 | |
|
17,245 | 2021-10-04 | 0 | |
STRAPPS WALTER CHIEF SCIENTIFIC OFFICER |
|
9,000 | 2021-04-28 | 0 |
BARONE SAMUEL B. CHIEF MEDICAL OFFICER |
|
255,212 | 2021-04-12 | 0 |
LAUDER SCOTT CHIEF TECHNOLOGY OFFICER |
|
272,615 | 2021-02-23 | 0 |
REDMOND PRECILLIA CHIEF PEOPLE OFFICER |
|
25,489 | 2021-02-23 | 0 |
|
5,826,224 | 2021-02-05 | 3 | |
BELOFF GREGG CHIEF FINANCIAL OFFICER |
|
0 | 2021-02-05 | 0 |
|
4,836,106 | 2021-02-05 | 0 | |
|
4,836,106 | 2021-02-05 | 0 | |
ATLAS VENTURE ASSOCIATES X, L.P. ATLAS VENTURE ASSOCIATES X, LLC ATLAS VENTURE OPPORTUNITY FUND I, L.P. ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P. ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC |
|
5,254,365 | 2021-02-05 | 1 |
FORESITE CAPITAL MANAGEMENT V, LLC |
|
4,870,250 | 2021-02-05 | 0 |
UKNIS MARC CHIEF MEDICAL OFFICER |
|
0 | 2021-02-05 | 0 |
|
441,500 | 2020-10-19 | 0 | |
FORESITE CAPITAL MANAGEMENT V, LLC TANANBAUM JAMES B. PRESIDENT & CEO |
|
441,500 | 2020-08-14 | 0 |
|
0 | 2020-08-11 | 0 | |
|
0 | 2020-08-11 | 0 | |
|
0 | 2020-08-11 | 0 | |
|
0 | 2020-08-11 | 0 | |
|
0 | 2020-08-11 | 0 | |
|
0 | 2020-08-11 | 0 | |
RYAN DENNIS D CHIEF FINANCIAL OFFICER |
|
0 | 2020-08-11 | 0 |
ROME MICHAEL E VICE PRESIDENT |
|
0 | 2020-08-11 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASHIYA MONA - Director - > 10% Owner see footnotes |
2023-02-17 16:48:58 -0500 | 2023-02-15 | P | 14,329 | $23.00 | a | 299,205 | indirect | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 | ||
ASHIYA MONA - Director - > 10% Owner see footnotes |
2023-02-17 16:48:58 -0500 | 2023-02-15 | P | 37,049 | $23.00 | a | 773,607 | indirect | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 | ||
ASHIYA MONA - Director - > 10% Owner see footnotes |
2023-02-17 16:48:58 -0500 | 2023-02-15 | P | 57,318 | $23.00 | a | 1,196,825 | indirect | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 | ||
ORBIMED ADVISORS LLC - Director - > 10% Owner see footnotes ORBIMED CAPITAL GP VI LLC - Director - > 10% Owner see footnotes ORBIMED CAPITAL GP VIII LLC - Director - > 10% Owner see footnotes ORBIMED GENESIS GP LLC - Director - > 10% Owner see footnotes |
2023-02-17 16:43:10 -0500 | 2023-02-15 | P | 14,329 | $23.00 | a | 299,205 | indirect | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 | ||
ORBIMED ADVISORS LLC - Director - > 10% Owner see footnotes ORBIMED CAPITAL GP VI LLC - Director - > 10% Owner see footnotes ORBIMED CAPITAL GP VIII LLC - Director - > 10% Owner see footnotes ORBIMED GENESIS GP LLC - Director - > 10% Owner see footnotes |
2023-02-17 16:43:10 -0500 | 2023-02-15 | P | 37,049 | $23.00 | a | 773,607 | indirect | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 | ||
ORBIMED ADVISORS LLC - Director - > 10% Owner see footnotes ORBIMED CAPITAL GP VI LLC - Director - > 10% Owner see footnotes ORBIMED CAPITAL GP VIII LLC - Director - > 10% Owner see footnotes ORBIMED GENESIS GP LLC - Director - > 10% Owner see footnotes |
2023-02-17 16:43:10 -0500 | 2023-02-15 | P | 57,318 | $23.00 | a | 1,196,825 | indirect | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 | ||
ACCESS INDUSTRIES HOLDINGS LLC - > 10% Owner |
2023-02-17 16:42:32 -0500 | 2023-02-15 | P | 434,783 | $23.00 | a | 3,141,759 | direct | -1.237 | -0.2394 | 1.3168 | 3 | -2.6736 | 5 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
DISC MEDICINE INC IRON | 2023-03-24 22:15:03 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 21:45:03 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 21:15:03 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 20:45:03 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 20:15:04 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 19:45:03 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 19:15:04 UTC | -1.316 | 6.136 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 18:45:04 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 18:15:03 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 17:45:03 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 17:15:03 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 16:45:03 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 16:15:03 UTC | -1.1646 | 5.9846 | 10000 |
DISC MEDICINE INC IRON | 2023-03-24 15:45:03 UTC | -1.1646 | 5.9846 | 10000 |
DISC MEDICINE INC IRON | 2023-03-24 15:15:03 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 14:45:03 UTC | -1.1646 | 5.9846 | 30000 |
DISC MEDICINE INC IRON | 2023-03-24 14:15:03 UTC | -1.1646 | 5.9846 | 10000 |
DISC MEDICINE INC IRON | 2023-03-24 13:45:03 UTC | 1.294 | 3.276 | 10000 |
DISC MEDICINE INC IRON | 2023-03-24 13:15:04 UTC | 1.294 | 3.276 | 10000 |
DISC MEDICINE INC IRON | 2023-03-24 12:45:03 UTC | 1.294 | 3.276 | 10000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | IRON | -130.0 shares, $-2585.7 | 2022-12-31 | N-PORT |